📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Commentary on Keyes and Patrick: Changes in psychedelic use in the United States may require changes in our narrative of psychedelic harms (2023)

First Author: Morgan C

Attributed to: Reducing relapse in alcohol dependence with the NMDA receptor antagonist, ketamine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/add.16367

PubMed Identifier: 37919093

Publication URI: http://europepmc.org/abstract/MED/37919093

Type: Journal Article/Review

Parent Publication: Addiction

Issue: 12

ISSN: 0965-2140